Melky Cabrera’s contract is not evidence that the drug program is broken

49 Comments

As soon as the news broke that Melky Cabrera is signing with the Blue Jays, several people in my Twitter timeline said things to the effect that it must be the case that baseball’s drug testing system is broken if someone fresh off a PED suspension can sign a two-year, $16 million deal. And I get the frustration I suppose, because no one likes to see cheaters prosper, but whatever you think of this deal, it cannot reasonably be interpreted as an indictment of the drug testing system.

Based on his last two seasons, Melky Cabrera was poised to make something like $40 million bucks in free agency. Maybe more. And now, though he is not going to be hurting or anything, he’s going to make less than half that.  Say what you want about the drug testing system, but tens of millions of dollars in lost wages is no small penalty.

Now, that doesn’t mean that Cabrera’s use of PEDs didn’t still somehow help him. I’ll acknowledge that $16 million over two years may still be more than he ever could have got if he never took PEDs.  But we don’t know. We simply have no way of knowing how much of Cabrera’s improvement over the past two years was a function of PEDs and how much of it was natural improvement as he reached an age when most players put up their best years. Maybe he would have turned into the player his potential always suggested he might, in which case he’d still be making a good living. Maybe he wouldn’t have. If anyone claims to know this for sure, they’re making crap up, because it’s unknowable with current science and baseball analytics.

But no matter what amount of advantage he still realized, it’s on Cabrera, human nature and the incentives any person — and any team like the Blue Jays — is subject to, not baseball’s drug program.  Just as no laws, no matter how tough, can eradicate crime, no drug testing program can eradicate cheating. People will still do it from time to time. And when they do, they run the risk of getting caught. And when they get caught, they are punished. As Melky Cabrera was punished, to the tune of tens of millions of dollars.

Still not good enough for you? OK, that’s your right to think so. But know that the only logical conclusion to such thinking is to advocate for a lifetime ban for first time drug users. Because that’s the only thing that would have kept a team from taking a chance on Melky Cabrera like the Blue Jays are.  And while you may disagree, I think such a thing would be way too damn harsh.

Report: Diamondbacks acquire Steven Souza from Rays; Yankees land Brandon Drury

AP Photo
9 Comments

Update (6:35 PM ET): This is a three-team deal also involving the Diamondbacks, per Nick Piecoro of the Arizona Republic. The Diamondbacks will receive outfielder Steven Souza from the Rays and second baseman Brandon Drury will head to the Yankees. Lefty reliever Anthony Banda will go to the Rays, Piecoro adds. The Diamondbacks will also receive prospect Taylor Widener from the Yankees, per Joel Sherman of the New York Post. MLB.com’s Steve Gilbert adds that the Rays will get two players to be named later from the D-Backs.

Souza, 28, is earning $3.55 million in his first of three years of arbitration eligibility, so the Rays are presumably saving money in moving him. Last season, Souza hit a productive .239/.351/.459 with 30 home runs, 78 RBI, 78 runs scored, and 16 stolen bases in 617 plate appearances. Souza’s arrival almost certainly pushes Yasmany Tomas out of a starting gig.

Drury, 25, has played a handful of positions in his brief major league career. Last year, he played second base in Arizona, batting .267/.317/.447 with 13 home runs and 63 RBI in 480 PA.

Banda, 24, made his major league debut last season, posting an ugly 5.96 ERA with a 25/10 K/BB ratio in 25 2/3 innings. The peripherals suggest he pitched better than his ERA indicated.

Widener, 23, was selected by the Yankees in the 12th round of the 2016 draft. This past season with High-A Tampa, he pitched 119 1/3 innings and posted a 3.39 ERA with a 129/50 K/BB ratio. MLB Pipeline rated Widener as the 14th-best prospect in the Yankees’ system.

*

Robert Murray of FanRag Sports reports that the Rays will acquire second base prospect Nick Solak from the Yankees. The Yankees’ return is presently not known.

Solak, 23, was selected by the Yankees in the second round of the 2016 draft. He spent last season between High-A Tampa and Double-A Trenton, hitting a combined .297/.384/.452 with 12 home runs, 53 RBI, 72 runs scored, and 14 stolen bases.

MLB Pipeline ranked Solak as the eighth-best prospect in the Yankees’ system and the fifth-best second base prospect in baseball, praising him for his ability to hit line drives as well as his speed.